Tom 14, Nr 3 (2020)
Wybrane problemy kliniczne
Opublikowany online: 2020-06-25
Wyświetlenia strony
414
Wyświetlenia/pobrania artykułu
159
Problemy zdrowotne podróżnych z upośledzoną odpornością
Forum Medycyny Rodzinnej 2020;14(3):100-113.
Streszczenie
W ostatnich latach na całym świecie obserwuje się spektakularny wzrost liczby międzynarodowych podróży (chwilowo przystopowany przez pandemię COVID-19). Podróżują wszyscy, dorośli i dzieci, pacjenci z chorobami przewlekłymi i z upośledzoną odpornością. Odwiedzając regiony świata charakteryzujące się uciążliwymi warunkami klimatycznymi i sanitarnymi podróżni narażeni są na ekspozycje patogenów przenoszonych przez owady, drogą oddechową, pokarmową i płciową. Celem pracy jest omówienie problemów zdrowotnych związanych z podróżowaniem u osób z upośledzoną odpornością, pacjentów z chorobami nowotworowymi, autoimmunologicznymi, po przeszczepach, pacjentów po splenektomii, zakażonych HIV. Uwzględniono najczęstsze schorzenia oraz powikłania zdrowotne związane z podróżą, takie jak biegunki, infekcje dróg oddechowych, choroby skóry, choroby transmisyjne (malaria, zakażenia arbowirusowe). Przedstawiono podstawowe sposoby zapobiegania problemom zdrowotnym przed i w trakcie podróży (porada lekarska, immuno- i chemioprofilaktyka).
Słowa kluczowe: podróżowanieupośledzona odpornośćzagrożenia zdrowotneprofilaktyka
Referencje
- Askling HH, Dalm VA. The medically immunocompromised adult traveler and pre-travel counseling: status quo 2014. Travel Med Infect Dis. 2014; 12(3): 219–228.
- Patel RR, Liang SY, Koolwal P, et al. Travel advice for the immunocompromised traveler: prophylaxis, vaccination, and other preventive measures. Ther Clin Risk Manag. 2015; 11: 217–228.
- Wieten RW, Leenstra T, Goorhuis A, et al. Health risks of travelers with medical conditions – a retrospective analysis. J Travel Med. 2012; 19(2): 104–110.
- Committee to Advise on Tropical Medicine and Travel (CATMAT). The immunocompromised traveler. An advisory Committee Statement (ACS). Canada Commun Dis Rep 2007; 33(ACS-4): 1–24, indexed in Pubmed: 17520776.
- Loutan L. Vaccination of the immunocompromised patient. Biologicals. 1997; 25(2): 231–236.
- Dekkiche S, de Vallière S, D'Acremont V, et al. Travel-related health risks in moderately and severely immunocompromised patients: a case-control study. J Travel Med. 2016; 23(3).
- Baaten GG, Geskus RB, Kint JA, et al. Symptoms of infectious diseases in immunocompromised travelers: a prospective study with matched controls. J Travel Med. 2011; 18(5): 318–326.
- Rello J, Manuel O, Eggimann P, et al. ESGCIP and ESGITM. Management of infections in critically ill returning travellers in the intensive care unit-II: clinical syndromes and special considerations in immunocompromised patients. Int J Infect Dis. 2016; 48: 104–112.
- Angelo KM, Kozarsky PE, Ryan ET, et al. What proportion of international travellers acquire a travel-related illness? A review of the literature. J Travel Med. 2017; 24(5).
- Bialy C, Horne K, Dendle C, et al. International travel in the immunocompromised patient: a cross-sectional survey of travel advice in 254 consecutive patients. Intern Med J. 2015; 45(6): 618–623.
- van Aalst M, van Ruissen MCE, Verhoeven R, et al. Travel-related health problems in the immunocompromised traveller: An exploratory study. Travel Med Infect Dis. 2018; 25: 50–57.
- Hochberg NS, Barnett ED, Chen LH, et al. International travel by persons with medical comorbidities: understanding risks and providing advice. Mayo Clin Proc. 2013; 88(11): 1231–1240.
- Allen JE, Patel D. Enquiries to the United Kingdom National Travel Advice Line by healthcare professionals regarding immunocompromised travellers. J Travel Med. 2016; 23(3).
- LaRocque RC, Rao SR, Lee J, et al. Global TravEpiNet Consortium. Global TravEpiNet: a national consortium of clinics providing care to international travelers--analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009-2011. Clin Infect Dis. 2012; 54(4): 455–462.
- Uslan DZ, Patel R, Virk A. International travel and exposure risks in solid-organ transplant recipients. Transplantation. 2008; 86(3): 407–412.
- Leder K, Tong S, Weld L, et al. GeoSentinel Surveillance Network. Illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network. Clin Infect Dis. 2006; 43(9): 1185–1193.
- Mikati T, Taur Y, Seo SK, et al. International travel patterns and travel risks of patients diagnosed with cancer. J Travel Med. 2013; 20(2): 71–77.
- Ericsson C. Travellers with pre-existing medical conditions. International Journal of Antimicrobial Agents. 2003; 21(2): 181–188.
- Roukens AHE, van Dissel JT, de Fijter JW, et al. Health preparations and travel-related morbidity of kidney transplant recipients traveling to developing countries. Clin Transplant. 2007; 21(4): 567–570.
- Aung AK, Trubiano JA, Spelman DW. Travel risk assessment, advice and vaccinations in immunocompromised travellers (HIV, solid organ transplant and haematopoeitic stem cell transplant recipients): A review. Travel Med Infect Dis. 2015; 13(1): 31–47.
- Boggild AK, Sano M, Humar A, et al. Travel patterns and risk behavior in solid organ transplant recipients. J Travel Med. 2004; 11(1): 37–43.
- Wingard JR, Hsu J, Hiemenz JW. Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology. Infect Dis Clin North Am. 2010; 24(2): 257–272.
- McCarthy AE, Mileno MD. Prevention and treatment of travel-related infections in compromised hosts. Curr Opin Infect Dis. 2006; 19(5): 450–455.
- Castelli F, Patroni A. The human immunodeficiency virus-infected traveler. Clin Infect Dis. 2000; 31(6): 1403–1408.
- Salit IE, Sano M, Boggild AK, et al. Travel patterns and risk behaviour of HIV-positive people travelling internationally. CMAJ. 2005; 172(7): 884–888.
- Sherrard AW, McCarthy AE. Travel patterns and health risks for patients infected with HIV. Travel Med Infect Dis. 2009; 7(5): 291–295.
- The Global Database on HIV-specific travel & residence restrictions. http://www.hivtravel.org (6.06.2020.).
- Kotton CN, Ryan ET, Fishman JA. Prevention of infection in adult travelers after solid organ transplantation. Am J Transplant. 2005; 5(1): 8–14.
- Chiche L, Lesage A, Duhamel C, et al. Posttransplant malaria: first case of transmission of Plasmodium falciparum from a white multiorgan donor to four recipients. Transplantation. 2003; 75(1): 166–168.
- Wilson ME, Weld LH, Boggild A, et al. GeoSentinel Surveillance Network. Fever in returned travelers: results from the GeoSentinel Surveillance Network. Clin Infect Dis. 2007; 44(12): 1560–1568.
- Bhadelia N, Klotman M, Caplivski D. The HIV-positive traveler. Am J Med. 2007; 120(7): 574–580.
- Jackson Y, Dang T, Schnetzler B, et al. Trypanosoma cruzi fatal reactivation in a heart transplant recipient in Switzerland. J Heart Lung Transplant. 2011; 30(4): 484–485.
- Freedman DO, Weld LH, Kozarsky PE, et al. GeoSentinel Surveillance Network. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med. 2006; 354(2): 119–130.
- Lortholary O, Charlier C, Lebeaux D, et al. Fungal infections in immunocompromised travelers. Clin Infect Dis. 2013; 56(6): 861–869.
- Biggs HM, Galloway RL, Bui DM, et al. Leptospirosis and human immunodeficiency virus co-infection among febrile inpatients in northern Tanzania. Vector Borne Zoonotic Dis. 2013; 13(8): 572–580.
